Member Directory
WuXi AppTec is a leading open-access R&D capability and technology platform with operations in China, USA, Germany and Iceland. As an innovation-driven and customer-focused company, WuXi AppTec provides a broad and integrated portfolio of services to help our partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities in small molecule, biologics, cell therapy and gene therapy, medical device testing, and molecular testing and genomics, WuXi is enabling more than 2000 collaborators from more than 30 countries to bring innovative healthcare products to patients.
Xampla is the leader in the development of plant protein materials
We take our inspiration, and our name, from the principle of exaptation – the concept that a trait which evolved for one purpose can be harnessed to serve an entirely different function.
Using the power of genome editing and synthetic biology, we’ve converted nature’s ultimate first-responder cell into a modular chassis, ready to be programmed to treat disease. We’re arming our delivery platform to carry a broad spectrum of therapeutic payloads – cytokines, antibodies, nucleic acids and more. We’ve designed these delivery vehicles to activate only on recognition of their chosen targets, unleashing their powerful cargo with exquisite precision.
We’re developing our multi-modal therapies to treat the most complex of diseases including cancer and autoimmunity.